Compare AMBO & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AMBO | BMRA |
|---|---|---|
| Founded | 2000 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 6.6M |
| IPO Year | 2010 | 1995 |
| Metric | AMBO | BMRA |
|---|---|---|
| Price | $2.33 | $2.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 10.7K | ★ 23.2K |
| Earning Date | 08-05-2025 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 337.04 | N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $9,469,000.00 | $5,311,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $100.42 | ★ N/A |
| Revenue Growth | ★ 0.82 | N/A |
| 52 Week Low | $1.47 | $0.40 |
| 52 Week High | $6.75 | $4.60 |
| Indicator | AMBO | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 55.18 | 47.46 |
| Support Level | $1.60 | $1.91 |
| Resistance Level | $2.43 | $2.23 |
| Average True Range (ATR) | 0.28 | 0.09 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 69.25 | 51.85 |
Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.